Metabolic syndrome vs. its components for prediction of cardiovascular mortality: A cohort study in Chinese elderly adults
- PMID: 22916057
- PMCID: PMC3418900
- DOI: 10.3724/SP.J.1263.2012.01172
Metabolic syndrome vs. its components for prediction of cardiovascular mortality: A cohort study in Chinese elderly adults
Abstract
Objective: The predictive value of the metabolic syndrome (MetS) for mortality from all-cause and cardiovascular disease (CVD) in the Chinese population is unclear. The aim of this present study was to compare MetS with its individual components as predictors of mortality in Chinese elderly adults.
Methods: A cohort of 1,535 subjects (994 men and 541 women) aged 50 years or older was selected from employees of a machinery factory in 1994 and followed until 2009. Cox models were used to estimate the hazard ratios (HRs) predicted by MetS according to the harmonized definition and by its individual components.
Results: The baseline prevalence of MetS was 28.0% in men and 48.4% in women. During a median follow-up of 15 years, 414 deaths occurred, of these, 153 participants died from CVD. Adjusted for age and gender, the HRs of mortality from all-cause and CVD in participants with MetS were 1.47 (95% confidence interval (CI): 1.20-1.80) and 1.96 (95%CI: 1.42-2.72), respectively, compared with those without MetS. Non-significant higher risk of CVD mortality was seen in those with one or two individual components (HR = 1.22, 95%CI: 0.59-2.50; HR = 1.82, 95%CI: 0.91-3.64, respectively), while a substantially higher risk of CVD mortality only appeared in those with 3, 4, or 5 components (HR = 2.81-3.72), compared with those with no components. On evaluating the MetS components individually, we found that, independent of MetS, only hypertension and impaired glucose predicted higher mortality.
Conclusions: The number of positive MetS components seems no more informative than classifying (dichotomous) MetS for CVD risks assessment in this Chinese cohort.
Keywords: Cardiovascular disease; Chinese adults; Cohort study; Metabolic syndrome.
Similar articles
-
Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study.Cardiovasc Diabetol. 2022 Nov 2;21(1):227. doi: 10.1186/s12933-022-01665-8. Cardiovasc Diabetol. 2022. PMID: 36324143 Free PMC article.
-
Metabolic syndrome and mortality in older adults: the Cardiovascular Health Study.Arch Intern Med. 2008 May 12;168(9):969-78. doi: 10.1001/archinte.168.9.969. Arch Intern Med. 2008. PMID: 18474761
-
Association of metabolic syndrome with risk of cardiovascular disease mortality and all-cause mortality among Malaysian adults: a retrospective cohort study.BMJ Open. 2021 Aug 18;11(8):e047849. doi: 10.1136/bmjopen-2020-047849. BMJ Open. 2021. PMID: 34408040 Free PMC article.
-
Prognostic interactions between cardiovascular risk factors.Dan Med J. 2014 Jul;61(7):B4892. Dan Med J. 2014. PMID: 25123126 Review.
-
Metabolic Syndrome for Cardiovascular Disease Morbidity and Mortality Among General Japanese People: A Mini Review.Vasc Health Risk Manag. 2020 Apr 17;16:149-155. doi: 10.2147/VHRM.S245829. eCollection 2020. Vasc Health Risk Manag. 2020. PMID: 32368073 Free PMC article. Review.
Cited by
-
Higher neutrophil to lymphocyte ratio is associated with renal dysfunction and cardiac adverse remodeling in elderly with metabolic syndrome.Front Cardiovasc Med. 2022 Sep 8;9:921204. doi: 10.3389/fcvm.2022.921204. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36158844 Free PMC article.
-
Prognostic Value of Metabolic Syndrome in Patients With Non-ST Elevated Myocardial Infarction Undergoing Percutaneous Coronary Intervention.Front Cardiovasc Med. 2022 Jun 23;9:912999. doi: 10.3389/fcvm.2022.912999. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35811732 Free PMC article.
-
Metabolic syndrome, its components and mortality: A population-based study.Med J Islam Repub Iran. 2019 Feb 27;33:11. doi: 10.34171/mjiri.33.11. eCollection 2019. Med J Islam Repub Iran. 2019. PMID: 31086790 Free PMC article.
-
Predicted Coronary Heart Disease Risk Decreases in Obese Patients After Laparoscopic Sleeve Gastrectomy.World J Surg. 2018 Jul;42(7):2173-2182. doi: 10.1007/s00268-017-4416-6. World J Surg. 2018. PMID: 29282509
-
Impaired Fasting Glucose Is the Major Determinant of the 20-Year Mortality Risk Associated With Metabolic Syndrome in Nondiabetic Patients With Stable Coronary Artery Disease.J Am Heart Assoc. 2017 Oct 27;6(11):e006609. doi: 10.1161/JAHA.117.006609. J Am Heart Assoc. 2017. PMID: 29079562 Free PMC article.
References
-
- Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005;28:1769–1778. - PubMed
-
- Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006;119:812–819. - PubMed
-
- Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49:403–414. - PubMed
-
- Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56:1113–1132. - PubMed
-
- Ravaglia G, Forti P, Maioli F, et al. Metabolic Syndrome: prevalence and prediction of mortality in elderly individuals. Diabetes Care. 2006;29:2471–2476. - PubMed
LinkOut - more resources
Full Text Sources